Cargando…

Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma

BACKGROUND: Malignant mesothelioma (MM) is an aggressive cancer of the pleural and peritoneal cavities caused by exposure to asbestos. Asbestos-induced mesotheliomas in wild-type mice have been used extensively as a preclinical model because they are phenotypically identical to their human counterpa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sneddon, Sophie, Patch, Ann-Marie, Dick, Ian M., Kazakoff, Stephen, Pearson, John V., Waddell, Nicola, Allcock, Richard J. N., Holt, Robert A., Robinson, Bruce W. S., Creaney, Jenette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455120/ https://www.ncbi.nlm.nih.gov/pubmed/28577549 http://dx.doi.org/10.1186/s12885-017-3382-6

Ejemplares similares

Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma
por: Robinson, Cleo, et al.
Publicado: (2015)

Discovery of new biomarkers for malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2015)

Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma
por: Sneddon, Sophie, et al.
Publicado: (2019)

Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum
por: Creaney, Jenette, et al.
Publicado: (2013)

Auto-Antibodies to β-F1-ATPase and Vimentin in Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2011)

ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms
por: Morré, D. James, et al.
Publicado: (2016)

Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms
por: Morré, D. James, et al.
Publicado: (2016)

Association of Biomarker Levels with Severity of Asbestos-Related Diseases
por: Park, Eun-Kee, et al.
Publicado: (2012)

How Our Continuing Studies of the Pre-clinical Inbred Mouse Models of Mesothelioma Have Influenced the Development of New Therapies
por: Robinson, Bruce W.S., et al.
Publicado: (2022)

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2022)

Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo
por: Greening, David W., et al.
Publicado: (2016)

Chrysotile Asbestos and Mesothelioma
por: Lemen, Richard A.
Publicado: (2010)

Hyaluronic acid in viscous malignant mesothelioma pleural effusion
por: Cheah, Hui Min, et al.
Publicado: (2020)

What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination
por: Redwood, Alec J., et al.
Publicado: (2022)

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencing
por: Patch, Ann-Marie, et al.
Publicado: (2018)

MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions
por: Birnie, Kimberly A., et al.
Publicado: (2019)

Asbestos and Mesothelioma: A Comment
por: Jargin, Sergei V.
Publicado: (2018)

Statins Do Not Alter the Incidence of Mesothelioma in Asbestos Exposed Mice or Humans
por: Robinson, Cleo, et al.
Publicado: (2014)

Calretinin as a blood-based biomarker for mesothelioma
por: Johnen, Georg, et al.
Publicado: (2017)

The use of whole exome sequencing and murine patient derived xenografts as a method of chemosensitivity testing in sarcoma
por: Calvert, Nicholas, et al.
Publicado: (2018)

Mesotheliomas in rats following inoculation with asbestos.
por: Wagner, J. C., et al.
Publicado: (1969)

Thymectomy and asbestos-induced mesotheliomas in rats.
por: Wagner, M. M.
Publicado: (1979)

Asbestos, mesothelioma and the legacy of shipbuilding in Belfast
por: Morrison, Patrick J
Publicado: (2008)

Asbestos Exposure and the Mesothelioma Incidence in Poland
por: Krówczyńska, Małgorzata, et al.
Publicado: (2018)

Software for Apportionment of Asbestos-Related Mesotheliomas
por: Ross, Robert M.
Publicado: (2016)

Immune marker expression of irradiated mesothelioma cell lines
por: Chang, Faith, et al.
Publicado: (2022)

Treatments affecting the rate of asbestos-induced mesotheliomas.
por: Wagner, J. C., et al.
Publicado: (1980)

Asbestos Burden Predicts Survival in Pleural Mesothelioma
por: Christensen, Brock C., et al.
Publicado: (2008)

Where There Is Asbestos, There Is Mesothelioma: Filling in the Data Blanks
por: Haynes, Rebecca Clay
Publicado: (2011)

Susceptibility and resistance in the genesis of asbestos-related mesothelioma
por: Bianchi, Claudio, et al.
Publicado: (2008)

Malignant Mesothelioma after Household Exposure to Asbestos
por: Saba, Raya, et al.
Publicado: (2013)

Malignant Peritoneal Mesothelioma Without Asbestos Exposure
por: Abbas, Hafsa, et al.
Publicado: (2019)

How asbestos and other fibers cause mesothelioma
por: Gaudino, Giovanni, et al.
Publicado: (2020)

Zeolites ameliorate asbestos toxicity in a transgenic model of malignant mesothelioma
por: Fan, Xiyong, et al.
Publicado: (2019)

Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels
por: Ramarao-Milne, P., et al.
Publicado: (2022)

Profile of soluble factors in pleural effusions predict prognosis in mesothelioma
por: Dick, I.M., et al.
Publicado: (2022)

Asbestos-induced peritoneal mesothelioma in a construction worker.
por: Fonte, Rodolfo, et al.
Publicado: (2004)

Modeling Mesothelioma Risk Associated with Environmental Asbestos Exposure
por: Maule, Milena Maria, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_c5tt7isiaauqbbjtbd9u9u1aqp